LeafNLP Demos
Back to explore

Report #2866321

Received Oct 16, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
56 yrs
State
TX
Recovered
Unknown
Vaccinated
Jun 27, 2025
Onset
Jun 27, 2025
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS1LG749—
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS2LG749—

Symptoms (1)

Underdose

Symptom narrative

Underdose; Underdose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 56-year-old male patient who received HBV (Engerix B) (batch number LG749, expiry date 13-SEP-2026) for prophylaxis. Co-suspect products included HBV (Engerix B) (batch number LG749, expiry date 13-SEP-2026) for prophylaxis. On 27-JUN-2025, the patient received the 1st dose of Engerix B. On 31-JUL-2025, the patient received the 2nd dose of Engerix B. On 27-JUN-2025, an unknown time after receiving Engerix B and Engerix B, the patient experienced accidental underdose (Verbatim: Underdose). On 31-JUL-2025, the patient experienced accidental underdose (Verbatim: Underdose). The outcome of the accidental underdose and accidental underdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-SEP-2025 The reporter reported that an adult patient had two doses of the series for Engerix-B, but they just realized that both doses were only 0.5 ml.